Lupus Science & Medicine

Papers
(The H4-Index of Lupus Science & Medicine is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
2021 DORIS definition of remission in SLE: final recommendations from an international task force97
Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lprmice52
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials45
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways35
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies32
Thoughts on COVID-19 and autoimmune diseases31
SARS-CoV-2 vaccines in patients with SLE29
Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to ac28
Living with systemic lupus erythematosus in 2020: a European patient survey27
High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus25
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials25
Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review25
Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review24
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis23
Impact of COVID-19 pandemic on SLE: beyond the risk of infection20
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria20
Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis19
Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–201519
Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus19
0.057237863540649